new glp 1 agonist for weight loss Hitting the Triple G Spot: The Triple G Top GLP-1 Agonists Balance Weight
Description
Stimulation of gluconeogenesis by long chain fatty acids and glucagon
DOI: 10.1001/jamanetworkopen.2022.31982
Wegovys approval was based on the STEP study
)
A recent meta-analysis involving 32,884 patients from 19 randomized controlled trials further confirmed a 23% reduction in all-cause mortality associated with GLP-1RAs use (OR = 0.77) (Rivera et al., 2024)
